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A New Route to Obtain Perfluorodecalin 
Nanocapsules as An Oxygen Carrier in Cosmetic 
Formulations
Abstract
The preparation of Perfluorodecalin (PFD) encapsulated silica nanocapsules 
via a two-step process method using a combination of emulsifiers (Pluronic 
127, purified Soy Lecithin and Polysorbate 80) to obtain first stabilized water 
nanoemulsions of PFD as a template, followed by “in situ” precipitation of 
silica is demonstrated herein. Our method differs from previously published 
sol-gel processes starting from TEOS (Tetraethyl Orthosilicate) or TMOS 
(Tetramethyl Orthosilicate) because Sodium Silicate was used as departing 
material, hydrolyzed under strictly controlled conditions as we describe in 
what follows. To obtain uniform sized nanocapsules we found essential to 
slow down the hydrolytic process, controlling the temperature, pH and ionic 
strength. Successful incorporation of PDF (20% wt) into the silica nanocapsule 
core was evident from EDAX analysis. Our aim was to propose PFD charged 
nano-silica carriers as a new approach to topical treatment of aging skin due to 
intrinsic instability of perfluorocarbon emulsions.
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Introduction
Perfluorocarbon Compounds (PFC) are chemically and biologically inert 
compounds, widely known as oxygen carriers. Their high gas-dissolving 
capacity comes from fluorine’s low polarizability. Their intermolecular 
forces are so weak that they behave as gas-like fluids, dissolving other 
substances of low cohesion, such as oxygen and nitrogen [1].
It has been described that they have oxygen solubilities similar to hemoglobin 
[2], which makes them ideal oxygen reservoirs for organ preservation before 
transplantation [3]. An interesting feature of PFC as oxygen transporters 
is that the dissolved oxygen degree is not affected by external factors such 
as temperature or pH, thus the oxygen uptake curve is linear [4,5]. PFC 
have been also used as artificial blood substitutes for transfusions, with 
few reported adverse side effects compared to the whole blood [5,6].
Most of PFC formulations have been developed and marketed for 
biomedical applications. Emulsions and micellar suspensions have been 
obtained using PEG-based surfactants, RPluronic surfactants and/or 
phospholipids, together with high-pressure homogenization or sonication
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to down-load droplet size. Fraker et al. found particle size to 
be a critical factor affecting oxygen mass transfer from PFC 
containing colloidal systems and optimized the manufacture 
of nano-scale emulsion [7]. PFC were also encapsulated into 
biodegradable nanoparticles composed of PEGylated PLGA, 
as enhancement agents for efficient re-oxygenation to cells 
and organisms [8].
Perfluorodecalin (PFD) is one of the most commonly used 
PFC. It was included in the first commercial PFC formulation 
(Fluosol DA 20%) developed for blood substitute [9]. PFD 
was also nano-encapsulated within a biodegradable polymeric 
shell, namely Poly (Lactide-co-Gylcolide) Acid (PLGA), to 
provide a more stable alternative to commercial ultrasound 
and NMR contrast agents [10]. A similar PFD-PLGA nano-
system was proposed as an artificial oxygen carrier for blood 
substitute formulations [11]. Silica nanocapsules were also 
evaluated to stabilize PFD for ultrasound imaging applications 
[12]. A high encapsulation percentage was obtained, while it 
was stated that the size could be easily controlled by changing 
the RPluronic concentrations.
However, in the field of cosmetics there are few scientific 
references, even if it has been shown that after introducing fully 
saturated PFD with O2(g) into an emulsion for the treatment 
of skin, beneficial and measurable cosmetic effects have been 
observed: an increase in the Oxygen partial pressure, reduction 
of the wrinkles and an increase of the skin moisture content 
[13]. The limited knowledge and poor understanding of the 
chemistry of PFD and others perfluorocarbon molecules as 
oxygen carriers, as well as the intrinsic difficulties to formulate 
into cosmetics molecules that have both hydrophobic and 
lipophobic character, and do not tend to dissolve in either 
aqueous or lipid phases to produce stable emulsions, prevents 
its use [14].
Several interesting uses of nanotechnology in cosmetics have 
been proposed, and nanomaterial’s are being employed or 
suggested as carriers of active substances [15]. In this line, 
Silica-based materials are some of the most commonly used. 
The synthetic varieties of Silica produced via sol-gel routes 
allow the design of nanoparticles which have highly ordered 
structures with controlled pore-size distribution, pore geometry, 
and pore network tortuosity [15].
Recently the preparation of PFD encapsulated Silica 
nanocapsules via a one-pot synthesis method starting from 
Tetramethyl Orthosilicate (TMOS) was proposed [12].
In this paper, we suggest a new route to obtain PFD encapsulated 




Perfluorodecalin (PFD, 95.5% cis-trans mixture) was purchased 
Sodium Silicate was provided by Mejorsil (Argentina), with 
the following composition, expressed as oxides:
Na2O 12.3%
SiO2 32.4%
Density(25°C) = 1.51 gml-1
Impurities analysis by Atomic Absortion (ppm) :Ni<0.03; 
Pb=0.23; Sb<0.6 ; Fe=17.8; Cd<0.02 ; Hg< 0.07. Demineralized 
water was bought from Torbidoni (Argentina) with a 
conductivity of 0.07 µS cm-1 and contents of Si<0.01 ppm.
Commercial Urea was purchased from Dalgar (Argentina) with 
a purity of 99.6%. The rest was essentially Biuret, coming as 
a by-product from its synthesis.
Synthesis of silica nanocapsules
First, we tried to follow the classical Stober work, preparing 
Silica nanoparticles by hydrolysis and condensation of TEOS 
on a template microemulsion of PFD + RPluronic F127 or 
PFD + RPluronicc 68 in water, buffered with Potassium 
Phosphate 0.1M. Gel formation was studied as a function of 
pH by adding HCl 4M solution at 4°C [16].
Due to poor results in the presence of PFD, we decided to 
follow an alternative route starting from Sodium Silicate.
The optimized procedure was as follows:
We dissolved RPluronic F127 (2.5% w/w) in water (77% w/w) 
at 40-50°C to obtain a clear solution, we then added Soy 
Lecithin (0.5% w/w), followed by PFD (20% w/w). The last 
was added very slowly, while the temperature was elevated to 
90°C stirring intensely at 3500 rpm. with an Ultra Turrax T 
18 basic disperser (Astral GmbH D-7801, Germany). PFD 
was slowly incorporated into an emulsion.
The pH spontaneously obtained was in the range 6-7 and was 
then adjusted to pH 12 with NaOH 0.5 M. Always stirring 
at 80-90°C, we added 2.0 M solution of Urea to reach a final 
from Inta-Trade (Germany). TEOS, Sodium Silicate, RPluorinc 
F-68, RPluoronic F-127, HCl and Urea PA were initially bought 
to Sigma-Aldrich. Sodium Phosphate buffer was prepared from 
P.A. drugs. Water was produced by Millipore Milli-Q water 
purification system.
Sigma’s Sodium Silicate (cat. 33844-3) had the following 
composition expressed as oxides:
Na2O 10.6%
SiO2 26.5%
Density(25oC) = 1.39 gml-1
Soy Lecithin was purified by solvent extraction (Acetone) 
from Lecsoy S provided by fabriQUIMICA (Argentina) and 
contained a small quantity of Polysorbate 80.
After the synthesis was optimized with pure drugs, for the 
scaling up we used commercial raw materials as follows:
PFD had the same origin as before.
RPluronic 127 was provided by BASF (Germany).
Ocimum Scientific Publishers                                                                       .03.                                                                                  Submit Manuscript    
                                                                                                                                                                                                         
Journal of Dermatology Study and Treatment                                                                                                                            https://doi.org/10.33513/JDST/1801-01
and size of the silica nanocapsules. As the microscope used 
(Philips CM 200) was also provided with an EDAX Apollo 
Zaluzec probe for elements quantification, it also helped us to 
estimate the retaining PFD into the silica nanocapsules. Briefly, 
a droplet of a sample containing nanocapsules was deposited 
onto a carbon-coated copper grid and air dried. Then scanned 
with the microscope.
Attenuated Total Reflectance Infrared Spectroscopy (ATR): 
Was performed using a Nicolet 8700 FTIR spectrometer 
provided with ATR in the range 4000-525 cm-1 and OMNIC 
version 7.3 software (Thermo Electron Co.)
Surface area and pore size by N2(g) adsorption: Was estimated 
on the samples using Micromeritcs Serial 1417 equipment at 
-196°C.
Results and Discussion
Tunning the synthesis of the empty silica 
nanoparticles: Effects of RPluronic 127 (P127), 
urea, concentration, and pH on the size of the 
nanoparticles
As may be seen in figure 1 the size of the silica nanoparticles 
depends on the presence or not of P127 and Urea (experiments 
signaled as (+) mean that the reagents were present, while (-) 
means absence). The size of the particles, measured by DLS 
starting from a Sodium Silicate solutions without the former 
was always bigger than 100 nm. While if P 127 and Urea 
were present during the synthesis obtention of smaller sizes 
was possible.
The obtained polydispersity in these screening experiments 
was very low (0.046-0.053).
concentration of Urea = 0.5 M, and at last Sodium Silicate 
solution 0.5 M to reach a final concentration of 0.02 M.
Silica nanoparticles containing PFD were slowly precipitated 
from the mass as a very fine white powder, changing the system 
from opalescent to milky-white.
The whole process lasted up to three days.
The obtained precipitate could not be filtered. It was separated 
by centrifugation at 3000 rpm. (Rolco, Argentina) and 
resuspended three times with water to wash out the impurities.
Then the precipitate was dried in an oven at 40°C.
Due to the fact that Urea is slowly hydrolyzed, acidifying the 
reaction media, Silica is precipitated on the Pluronic matrix 
incorporating emulsified PFD.
Characterisation
Dynamic light scattering: Dynamic Light Scattering (DLS) 
was employed at the beginning to determine the hydrodynamic 
diameter of the silica nanocapsules aggregates (NanoBrook 
90 Plus Particle Size Analyzer-Brookhaven Instruments). 
We re-suspended them in water or in ethanol before the 
measurements.
Scanning electron microscopy: Scanning Electron Microscopy 
(SEM) was used to characterize the morphology and size of 
the silica nanocapsules. A droplet of solution containing the 
nanocapsules was deposited on a silicon wafer and dried. The 
samples were imaged with a FESEM microscope (Supra 40 
Zeiss Field Emission Scanning Electron Microscope) operating 
at an acceleration voltage of 5 kV.
Transmission electron microscopy: Transmission Electron 
Microscopy (TEM) was also used to characterize the morphology 
Figure 1: DLS of silica nanoparticles (without PFD). Influence of P 127 and Urea.
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The size of nanoparticles, either with of without emulsion was also sensitive to the pH at which condensation occurs, as shown 
in figure 2 for microemulsion-free nanoparticles.
Figure 2: SEM images of empty silica nanoparticles synthesized at constant [Si] with variable pH without microemulsion.
At pH 12 translucent gels are obtained, which precipitate structured as long crystalline cylinders (Figure 3).




 at pH 12. Final Si(IV) concentration = 0.0065M.
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If the pH is buffered at a value around 8, big aggregates are obtained, mixed with spheres of circa 100 nm of diameter (Figure 4).




 at pH 8. Final Si(IV) concentration = 0.0065M.
Finally, in the pH range from 8 to 9, we could obtain non-disperse spherical nanoparticles in the range of 50 to 100 nm (Figure 5).




 at pH 9. Final Si(IV) concentration = 0.005M.
Journal of Dermatology Study and Treatment                                                                                                                             https://doi.org/10.33513/JDST/1801-01
 Submit Manuscript                                                                                  .06.                                                     Ocimum Scientific Publishers
Working at pH=9, if the final Si(IV) concentration increases, the size of the obtained nanoparticles becomes smaller and 
smaller (Figures 6 and 7).




 at pH 9. Final Si(IV) concentration = 0.075M.
Figure 7: SEM images of silica nanoparticles synthesized at constant pH with variable [Si] with microemulsion.
The overall reaction follows the formation of silanol groups:
Na2SiO3 + 3H2O
→≡≡≡ Si—OH
Which undergoes further condensation reactions, giving rise 
to nanoparticle growth:
≡≡≡ Si—OH + ≡≡≡ Si—OH →≡≡≡ Si—O—Si ≡≡≡
To obtain small and uniform sized particles, we found 
essential to slow down the hydrolytic process, controlling the 
temperature, pH and ionic strength of the reaction media while 
maintaining continuous stirring throughout it.
The hydrolytic process and the pH is controlled by the 
decomposition of urea into the reaction media [17].
Synthesis and composition of PFD encapsulated 
silica nanocapsules
We employed the optimized operative conditions as described 
in section 4.2.
The size and external characteristics of the PFD charged 
nanocapsules was similar to the empty ones.
The presence of PFD was determined by EDAX analysis 
coupled to TEM microscope.
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PHILIPS CM200 with EDAX APOLLO
Table 1: EDX analysis of PFD containing silica nanoparticles.
During the microscope scan, the different elements present 
were identified by their EDAX peaks. Carbon and copper 
peaks belonging to the sampling grid were subtracted from 
the total area. The FK peak at 0.6 KeV belonged to PFD, and 
allowed the system to calculate relative quantities of O, Si and 
F contained by the Nanocapsules (Table 1).
Figure 8: TEM micrographs of PFD containing silica nanoparticles. Note the homogeneous size and small 
diameter obtained.
It is interesting to note that even with the high vacuum 
employed in the transmission microscope, was found. ca. 1:1 
F:Si atomic ratio. The same analysis performed with pyrogenic 
silica nanospheres (ca.30 nm diameter) containing 50% w/w 
PFD showed a 1:10 F:Si atomic ratio. TEM micrographs are 
shown in figure 8.
Once the optimal synthesis conditions were chosen, PFD 
encapsulation (20% w/w) gave rise to monodisperse spherical 
nanoparticles with (23±3) nm diameter with BET surface area 
of (38.9 ± 1.1) m2/g, as determined from the N2(g) adsorption 
isotherms. The found surface area was coherently lower than 
the one declared for commercial pyrolytic-obtained silicas, 
as RAerosil 200 (200 m2/g) and RCab O Sil 150 (150 m2/g), 
which have a smaller mean size (12-14 nm).
The measured adsorption average pore width was of 11.6 nm. 
The isotherm adsorption and desorption plots showed very 
low hysteresis suggesting, as suspected, weak intermolecular 
forces between the gas and the PFD charged nanoparticles.
Our results with commercial sodium silicate, employing the 
optimized synthesis conditions, were nearly coincident with 
those obtained with the research reagents.
The relatively low level of impurities of the silicate, and biuret 
by-product coming from urea synthesis seemed not to interfere 
with our process. Biuret, once hydrolyzed renders CO2(g) and 
NH3 as well, contributing to pH regulation too. Showing 
that commercially “pure” raw materials as those tested in our 
experiments (water, sodium silicate, urea) could also be used 
to obtain nano-silica carriers for cosmetic topical applications 
with cost advantage.
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Conclusion
A positive cosmetic effect on the skin by PFD as Oxygen carrier 
has been demonstrated, but it is barely used because of the 
intrinsic formulation instability. In recent years there has been 
a spate interest relative to the application of nanotechnology 
in cosmetics, with nanostructures used as active substances, 
carriers and formulation aids [15].
In this work, we obtained Silica nanoparticles that could be 
employed to deliver Perfluorodecalin. First, we have obtained 
relatively stable microemulsions using specific experimental 
conditions and combinations of emulsifiers [14]. Then we 
have molded on the former, Silica nanoparticles loaded with 
Perfluorodecalin via one-pot condensation.
The synthetic method used allowed us to obtain an essentially 
monodisperse Silica population, whose mean size is bigger 
than that of well-known commercial materials obtained by 
the pyrolytic pathway who are usually employed to formulate 
cosmetics. The latter claim a BET surface area in the range of 
100 to 400 m2/g, and particle diameters between 7 and 20 nm.
Our method can be easily scaled-up starting from commercially 
available materials with a cost advantage over other synthetic 
pathways [17].
Regarding potential toxicity for cosmetic use, commercial Silica 
nanoparticles as mentioned above - which are even smaller than 
those obtained by our condensation process- have been used in 
cosmetic formulations for long. CIR Expert Panel concluded 
that Silica and Hydrated Silica were safe as used in cosmetics 
and personal care products [18]. They are also considered 
safe by the FDA and accomplish the general provisions of the 
Cosmetic Directives of the European Union [19]. Due to their 
controlled size in the range of 20 to 50 nm, our nanoparticles 
should penetrate the skin enough to deliver PFD, but not 
enough to affect the human body in a systemic way. Recently 
in vitro assessment of analog silica nano-capsules cytotoxicity 
was investigated [12], without showing any cytotoxic effect at 
low concentrations towards HepG2 and 3T3 cell lines.
In summary, we have been able to stabilize Silica nanoparticles 
containing PFD, who could act as effective vectors to introduce 
the molecule into stable cosmetic formulations. The research 
should continue, to further verify the ability of our nano-
device to help oxygenate the living human skin improving its 
barrier function.
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